The Effect of Vitamin D Supplementation on Symptoms of Depression in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Rudi Putranto, Kuntjoro Harimurti, Siti Setiati, Eka Dian Safitri, Siti Rizny F Saldi, Imam Subekti, Martina Wiwie S Nasrun, Hamzah Shatri

Abstract


Background: The effect of vitamin D supplementation on depressive  symptoms in people with type 2 diabetes is still up for debate. The aim of this paper was to investigate the effect of vitamin D supplementation on symptoms of depression in type 2 diabetic patients. Methods: The protocol for this review has been registered in PROSPERO:CRD42021231713. Searching for literature was conducted using Pubmed, EBSCOhost, and EMBASE. Randomised controlled trials (RCTs) regarding vitamin D supplementation in type 2 diabetic patients with depression were retrieved through a systematic search. The outcome measured was a change in depressive symptoms evaluated with any validated rating scale. Independent data extraction was conducted, and the study quality was assessed. A meta-analysis was carried out to calculate the improvement in depressive symptoms in the group receiving vitamin D and the control group. The available evidence in RCTs was analysed using the PRISMA approach, and clinical significance was determined using the GRADE system. Risk of bias was assessed using the Cochrane Risk of Bias Tool. Results: Four RCTs were reviewed and three RCTs were meta-analysed. In two studies, vitamin D was statistically effective in improving depressive symptoms in type 2 diabetic patients. Three randomised controlled trials  were included in the meta-analysis with 161 subjects using depression score as an outcome assessment. Vitamin D is significantly more effective than placebo (95% CI: -0.70 to - 0.08, p = 0.01). Conclusion: Vitamin D supplementation may improve the depressive symptoms in type 2 diabetic patients. Future research with different geographical areas and larger samples should be done to further assess the benefits.

Keywords


depression; type 2 diabetes mellitus; vitamin D

References


Roy T, Llyod CE. Epidemiology of depression and diabetes: a systematic review. Journal of Affective Disorders. 2012;S8–S21. doi: 10.1016/S0165- 0327(12)70004-6

Holt RIG, Groot M de, Golden SH. Diabetes and depression. Curr Diab Rep. 2014;14(6):491. doi: 10.1007/s11892-014-0491-3.

Anglin RES, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. British Journal of Psychiatry. 2013:202(2):100-7. doi: 10.1192/bjp.bp.111.106666

Nouwen A, Winkley K, Twisk J, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–6. doi: 10.1007/s00125- 010-1874-x. Epub 2010 Aug 14.

Fisher L, Glasgow RE, Strycker LA. The relationship between diabetes distress and clinical depression with glycaemic control among patients with type 2 diabetes. Diabetes Care. 2010;33(5):1034–6. doi: 10.2337/dc09-2175

Groves NJ, McGrath JJ, Burne TH. Vitamin D as a neurosteroid affecting the developing and adult brain. Annu Rev Nutr. 2014;34:117-41. doi: 10.1146/annurev-nutr-071813-105557

Penckofer S, Byrn M, Adams W, et al. Vitamin D supplementation improves mood in women with type 2 diabetes. J Diabetes Res. 2017;2017:8232863. doi: 10.1155/2017/8232863. Epub 2017 Sep 7.

Gowda U, Mutowo MP, Smith BJ, Wluka AE, Renzaho AMN. Vitamin D supplementation to reduce depression in adults: meta-analysis of randomized controlled trials. Nutrition. 2015;31:421-429S.

Spedding S. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 2014;6:1501-18.

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/ 10.1136/bmj.n71

National Institute for Health Research. http://www.crd.york.ac.uk/PROSPERO, registration number CRD42021231713.

Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials. BMJ. 2011;343:d5928.

Review Manager (RevMan) [Computer program]. Version 5.4. The Cochrane Collaboration, 2020.

Sterne JAC, Sutton AJ, Loannidis JPA, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta- analyses of randomised controlled trials. BMJ. 2011;343:d4002. doi: https://doi.org/10.1136/bmj.d4002

Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785-94. doi:10.1111/biom.12817

Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: Introduction GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:, 383-94.

Raygan F, Ostadmohammadi V, Bahmani F, Asemi Z. The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84(Pt A):50–5. Doi: 10.1016/j.pnpbp.2018.02.007

Omidian M, Mahmoudi M, Abshirini M, et al. Effects of vitamin D supplementation on depressive symptoms in type 2 diabetes mellitus patients: Randomized placebo-controlled double-blind clinical trial. Diabetes Metab Syndr: Clin Res Rev. 2019;13:2375-80. doi: 10.1016/j.dsx.2019.06.011

Fazelian S, Amani R, Paknahad Z, Khein S, Khajehali L. Effect of Vitamin D supplement on mood status and inflammation in Vitamin D deficient type 2 diabetic women with anxiety: A randomized clinical trial. Int J Prev Med. 2019;10:17. doi:10.4103/ijpvm.IJPVM_174_18

Mirzavandi F, Babaie S, Rahimpour S, et al. The effect of high dose of intramuscular vitamin D supplement injections on depression in patients with type 2 diabetes and vitamin D deficiency: A randomized controlled clinical trial. Obes Med. 2020;17:1-6. doi: 10.1016/j.obmed.2020.100192

Sterne JAC, Savocić J, Elbers RG, et al. RoB 2: a revised tool for assessing risk of bias in randomized tools. BMJ. 2019;366:l4898.

abousetta (https://stats.stackexchange.com/users/24137/abousetta), Meta- analysis: dealing with bias with a small number of studies, URL (version: 2013- 08-03): https://stats.stackexchange.com/q/66408

Geng C, Shaikh AS, Han W, Chen D, Guo Y, Jiang P. Asia Pacific Journal of Clinical Nutrition. 2019;28 (4): 689 – 94. doi: 10.6133/apjcn.201912_28(4).0003.

Li G, Mbuagbaw L, Samaan Z, et al. Efficacy of vitamin D supplementation in depression in adults: a systematic review. Journal of Clinical Endocrinology and Metabolism. 2014;99(3):757-67. doi:10.1210/jc.2013-345

Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013 Feb;202:100-7. doi: 10.1192/bjp.bp.111.106666. PMID: 23377209.

Mozaffari-Khosravi H, Nabizade L, Yassini-Ardakani SM, Hadinedoushan H, Barzegar K. The effect of 2 different single injections of high dose of vitamin D on improving the depression in depressed patients with vitamin D deficiency: a randomized clinical trial. J Clin Psychopharmacol. 2013;33(3): 378-85.

Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double-blind trial. J Intern Med. 2008;264(6):599-609. doi: 10.1111/j.1365-2796.2008.02008.x. Epub 2008 Sep 10. PMID: 18793245.

Penckofer S, Ridosh M, Adams W, et al. Vitamin D supplemetation for the treatment of depressive symptoms in women with type 2 diabetes: a randomized clinical trial. Journal of Diabetes Research. 2022; ID: 4090807: 1 – 10. https://doi.org/10.1155/2022/4090807

Khoraminya N, Therani-Doost M, Jayazeri S, Hosseini A, Djazayery A. Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust NZJ Psychiatr. 2013;47(3): 271-5. doi: 10.1177/0004867412465022

Kjærgaard M, Joakimsen R, Jorde R. Low serum 25-hydroxyvitamin D levels are associated with depression in an adult Norwegian population. Pyschiatr Res. 2011;190(2-3):221-5. doi: 10.1016/j.psychres.2011.06.024

Hoogendijk WJ, Lips p, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatr. 2008;65(5):508- 12. doi: 10.1001/archpsyc.65.5.508

Zhao G, Ford ES, Li C, Balluz LS. No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. Br J Nutr. 2010;104(11):1696-702. doi: 10.1017/S0007114510002588

Pan A, Lu L, Franco OH, Yu Z, Li H, Lin X. Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. J Affect Disord 2009;118(1-3):240-3. doi: 10.1016/j.jad.2009.02.002


Full Text: PDF

Refbacks

  • There are currently no refbacks.